|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation
Related Content
Trending on Applied Clinical Trials Online
1
Applying Systems Thinking to the Future of Clinical R&D
2
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
3
ACT Brief: CRO Partnership in Program Recruitment, Psychedelic Trial Design Guidance, and Breast Cancer Pathway Inhibitor
4
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
5